Brief: IL Dong Pharmaceutical receives patent
Nov 17 (Reuters) - IL Dong Pharmaceutical Co Ltd 249420.KS
:
* Says it received China patent on Nov. 16, for
streptococcus dysgalactiae ID9103 and method for production of
hyaluronic acid using the same
* Patent application number is 201280048001.2
Source text in Korean: https://goo.gl/7xU0wG
Further company coverage: 249420.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Il Dong Pharmaceutical
See all newsBrief: Il Dong Pharmaceutical Q4 Operating Profit 8 Billion Won, Down 5.7% From Year Earlier
To Divest 15.85 Billion Won Worth Of Shares In D&D Pharmatech
Brief: Il Dong Pharmaceutical Q3 Operating Profit 6.8 Billion Won, Up 87.6% From Year Earlier
Brief: Il Dong Pharmaceutical Q2 Operating Profit 596 Million Won, Down 41.4% From Year Earlier
Brief: Il Dong Pharmaceutical Q1 Operating Profit 4.2 Billion Won, Up 4275% From Year Earlier